Viewing Study NCT04652258


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-04-24 @ 11:17 PM
Study NCT ID: NCT04652258
Status: TERMINATED
Last Update Posted: 2024-11-01
First Post: 2020-11-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pyrexia Management Using an IL-6 Antibody in BRAF+ Melanoma Patients Treated with Dabrafenib/ Trametinib +/- Immunotherapy
Sponsor: University of Zurich
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module